Alnylam Pharmaceuticals
ALNY
#786
Rank
S$40.89 B
Marketcap
S$305.61
Share price
-2.42%
Change (1 day)
-47.54%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company